Medical/Pharmaceuticals

Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented in "Game Changing" Session at EAU

MELBOURNE, Australia, March 14, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89 Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (Clinic...

2023-03-14 05:11 1908

Austco Augments Industry-leading Nurse Call and Healthcare Communications Solutions with 4D Imaging Radar Fall Detection by Vayyar

International partnership will see sensor installations in senior care facilities in all of Austco's operating regions, includingAustralia, the UK, Canada, and the US. DALLAS and TEL AVIV, Israel, March 13, 2023 /PRNewswire/ -- Austco , an international manufacturer of n...

2023-03-13 23:08 2434

Ping An Health achieves enhancement in managed care healthcare

Cumulative paying users continue to increase Gross margin increased significantly to 27.3% HONG KONG and SHANGHAI, March 13, 2023 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor" or "Ping An Health"; Stock Code: 1833.HK) announced its 2022 annual results. ...

2023-03-13 21:13 4221

Annabella - the first breast pump to simulate a baby's tongue, was launched in Israel, taking an estimated 10% of the monthly Israeli breast pump market, in February. The company is raising funds to accelerate penetration to the UK and US markets

TEL AVIV, Israel, March 13, 2023 /PRNewswire/ -- Annabella, the world's first breast pump to simulate a baby's tongue during the pumping process, was recently launched inIsrael after five years of development. The Annabella made its market debut onFebruary 16, 2023, and quickly captured an estima...

2023-03-13 21:02 2230

Patient Enrollment Completed for the Phase 3 Trial of Boan Biotech's Aflibercept Intravitreous Injection in China

YANTAI, China, March 13, 2023 /PRNewswire/ -- Luye Pharma Group today announced that patient enrollment has been completed for the Phase 3 clinical study (comparative clinical study of efficacy and safety) of BA9101 (Aflibercept Intravitreous Injection) inChina. This is an investigational ophthal...

2023-03-13 20:36 2599

Qritive Launches QAi Prostate: Advanced AI-Powered Prostate Cancer Diagnosis Tool for Pathologists

QAi Prostate leverages advanced machine learning algorithms to accurately identify and classify malignant and benign areas in prostate biopsies, improving diagnostic accuracy and patient outcomes    SINGAPORE, March 13, 2023 /PRNewswire/ -- Qritive , a leading provider of d...

2023-03-13 14:25 2746

Everest Medicines Announces Silicon Valley Bank Developments Have Minimal Impact on Company

SHANGHAI, March 13, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing, manufacturing and commercializing transformative pharmaceutical products and vaccines inGreater China and other parts of Asia, would like to announce that it considers its...

2023-03-13 07:51 3120

NCODA International Executive Council to Advance Medically Integrated Oncology Worldwide

CAZENOVIA, N.Y., March 10, 2023 /PRNewswire/ -- NCODA a non-profit organization whose Mission is to empower the medically-integrated oncology team to deliver positive, patient-centered outcomes is proud to announce the formation of its International Executive Council (IEC). The IEC will provide i...

2023-03-10 02:30 2385

Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics

ZUG, Switzerland, March 9, 2023 /PRNewswire/ -- Alnylam Pharmaceuticals, Inc.  (Nasdaq: ALNY), the leading RNAi therapeutics company, andMedison Pharma  ("Medison"), a global pharma company focused on providing access to highly innovative ...

2023-03-09 20:01 2412

NIPPON EXPRESS HOLDINGS Strengthens Pharmaceutical Logistics Quality System Globally

- Compiles "NX-Pharma Global Quality Manual" and Appoints Head of NX-Pharma Global Quality - TOKYO, March 9, 2023 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC., based in Tokyo, has compiled the NX-Pharma Global Quality Manual, applicable as of Sunday, January 1, 2023, to unify and standardize ph...

2023-03-09 14:57 2386

Servier Announces Partnership with QIAGEN to Develop New mIDH1 Companion Diagnostic Test to Support Servier's Onco-hematology Portfolio

PARIS, March 9, 2023 /PRNewswire/ -- Servier, a global pharmaceutical group, today announced it has entered into a strategic partnership with QIAGEN, a leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the buil...

2023-03-09 14:30 1647

DIGITAL THERAPEUTICS STARTUP RESPIREE™ GAINS US FDA CLEARANCE FOR ITS RS001 CARDIO-RESPIRATORY WEARABLE

SINGAPORE, March 9, 2023 /PRNewswire/ -- Digital therapeutics startup Respiree  has received the United States Food and Drug Administration's 510(k) clearance for its RS001 cardio-respiratory wearable. Illustrative Ima...

2023-03-09 08:14 6214

Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX® Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)

– CELLEX ECP is now available for reimbursement in Japan for patients who are steroid-resistant or -intolerant and suffering from cGvHD – DUBLIN, March 9, 2023 /PRNewswire/ -- Mallinckrodt plc, (NYSE American: MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, tod...

2023-03-09 05:00 2208

Telix to Showcase Additional ZIRCON Phase III Data in Kidney Cancer Imaging and Theranostic Pipeline Developments at EAU

MELBOURNE, Australia, March 9, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations from the Company's carbonic anhydrase IX (CAIX) targeting kidney and bladder cancer programs at the 38th Annual European Association of Urology (EAU) Cong...

2023-03-09 04:51 2391

JW Therapeutics Announces Initiation of Clinical Study of Carteyva® in First-line Treatment in Patients with High-Risk Large B-Cell Lymphoma

SHANGHAI, March 8, 2023  /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of clinical study of Carteyva® (relmacabtagene autoleucel inje...

2023-03-08 17:30 3172

IVI launches global study to determine the burden of HPV among girls and women

SEOUL, South Korea, March 8, 2023 /PRNewswire/ -- The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, announced the start of a multi-country study to better understand...

2023-03-08 16:40 1893

ONEDAY BIOTECH to unveil 'One Drilling System' at IDS 2023

* One Drilling System Completing the Implant Procedure with Just One Drilling Exclusively * Company Specializing in Implants Pursuing 'One-Day-Completion Implant' SEOUL, South Korea, March 8, 2023 /PRNewswire/ -- ONEDAY BIOTECH (CEO Kim Jin -hwan), a dental product manufacturer specializing in...

2023-03-08 07:00 3293

Martech platform Ortto celebrates record growth on the anniversary of its rebrand

The unified customer data, analytics, and marketing automation platform Ortto, formerly Autopilot, continues to see double-digit monthly growth a year on from its rebrand. The martech company now has more than 3,000 customers globally and was recognized in 49 categories in G2's biannual report. ...

2023-03-08 03:14 2560

Argon Medical Devices Modernizes Portal Vein Access with the Launch of the TRAVELER™ Series

PLANO, Texas, March 8, 2023 /PRNewswire/ -- Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, introduces the TRAVELER™ Portal Vein Access Series as the newest addition to its portal vein access pr...

2023-03-08 01:39 2574

Medlab Asia and Asia Health returns to Thailand after securing deals worth US$35m in 2022

BANGKOK, March 7, 2023 /PRNewswire/ -- Informa Markets and IMPACT Exhibition Management Co.,Ltd. have confirmed that Medlab Asia and Asia Health, a major healthcare event, will return toThailand following the success of the 2022 edition, after shining a spotlight on the growth of healthcare and l...

2023-03-07 16:49 2408
1 ... 125126127128129130131 ... 397